IL13-PE38: Phase I/II

Preliminary results from a U.S. Phase I/II trial in 18 patients showed

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE